Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.
Clinical trial NCT04157348 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04157348
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-29
- Primary completion
- 2023-08-10
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.